Edition Draft - Medsafe
Guideline on the Regulation of Therapeutic Products in New Zealand Part 4 : Manufacture of medicines Edition Draft October 2014
Download Edition Draft - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzRedipred – Data Sheet Page 3 of 11 dosage appear to be important factors in determining suppression of the pituitary adrenal axis and response to stress on cessation of steroid treatment.
Related documents
APPLICATION PACK - COMMUNITY PHARMACY / …
www.buttercups.co.uk1 © buttercups training ltd february 2018 application pack - community pharmacy / hospital level 2 certificate in pharmacy service skills (nvq) (qcf) with ...
APPLICATION PACK - COMMUNITY PHARMACY / …
www.buttercups.co.uk1 © buttercups training ltd january 2018 application pack - community pharmacy / hospital level 3 diploma in pharmacy service skills (nvq) (qcf) with underpinning ...
BURSARY INFORMATION PACK - Pages
www.dhet.gov.za- 1 – Updated 13 February 2011 BURSARY INFORMATION PACK The “where”, “what” and “how” of applying for bursaries for students in Matric in 2011 and plan on going to university in 2012.
HERALD Classified Page 7-25-18 indd
www.grantherald.comATTORNEYS •Westrom Law Offi ce, LLC Torrey N. Westrom Attorney at Law PO Box 299, Elbow Lake, MN 56531 Probate - Wills 218-685-6299 westlaw@runestone.net
UK Public Assessment Report - GOV.UK
www.mhra.gov.ukUK Public Assessment Report . Flarin 200 mg soft capsules (ibuprofen) UK Licence No: PL 42459/0002. Infirst Healthcare Limited
Community Start-up and Application Kit - …
www.webstercare.com.aupart a flowchart part b checklist part c faq’s for community clients part d doctor’s faq’s part e carer’s faq’s part f patient profile alternatives
Annex 9 Guide to good storage practices for …
www.who.int127 — aid in the processing of the drug delivery system during its manufacture; — protect, support or enhance stability, bioavailability, or patient